TTT

TAKARA BIO INC.

No trades
See on Supercharts
Market capitalization
‪721.95 M‬EUR
‪111.20 M‬EUR
‪542.69 M‬EUR
‪46.06 M‬
Beta (1Y)
0.26

About TAKARA BIO INC.

Headquarters
Kusatsu
Employees (FY)
‪1.79 K‬
Founded
2002
ISIN
JP3460200003
FIGI
BBG000RHK456
Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. It provides products and services for basic research and industrial application in life sciences. These include services for the research and manufacturing of regenerative medicine products and the development of gene therapy products for synovial sarcoma. It also develops, manufactures, and sells reagents for polymerase chain reaction (PCR) tests for COVID-19. The company was founded on April 1, 2002 and is headquartered in Kusatsu, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TAKARA BIO INC. stocks are traded under the ticker TF2.
TAKARA BIO INC. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
TF2 earnings for the last quarter are 0.04 EUR per share, whereas the estimation was 0.04 EUR resulting in a −2.31% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about TAKARA BIO INC. earnings.
TAKARA BIO INC. revenue for the last quarter amounts to ‪62.93 M‬ EUR despite the estimated figure of ‪71.04 M‬ EUR. In the next quarter revenue is expected to reach ‪75.88 M‬ EUR.
Yes, you can track TAKARA BIO INC. financials in yearly and quarterly reports right on TradingView.
TF2 net income for the last quarter is ‪−5.97 M‬ EUR, while the quarter before that showed ‪4.84 M‬ EUR of net income which accounts for −223.30% change. Track more TAKARA BIO INC. financial stats to get the full picture.
TAKARA BIO INC. dividend yield was 2.42% in 2022, and payout ratio reached 31.59%. The year before the numbers were 1.47% and 20.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, TF2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAKARA BIO INC. stock right from TradingView charts — choose your broker and connect to your account.
TF2 reached its all-time high on May 8, 2013 with the price of 30.00 EUR, and its all-time low was 0.25 EUR and was reached on Dec 16, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪1.79 K‬ employees. See our rating of the largest employees — is TAKARA BIO INC. on this list?
We've gathered analysts' opinions on TAKARA BIO INC. future price: according to them, TF2 price has a max estimate of 13.38 EUR and a min estimate of 7.91 EUR. Read a more detailed TAKARA BIO INC. forecast: see what analysts think of TAKARA BIO INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAKARA BIO INC. EBITDA is ‪42.00 M‬ EUR, and current EBITDA margin is 32.35%. See more stats in TAKARA BIO INC. financial statements.